A machine learning-enabled speech-based screening tool for AD/ADRD caregivers

Awardee Organization(s): University of Southern California
Principal Investigator(s): Maja Matarić, PhD
Official Project Title: An Accessible Machine Learning-Based ADRD Screening Tool for Families and Caregivers
AITC Partner: PennAITech
Website(s): www.robotics.usc.edu/~maja

The goal of this project is to develop an app-based screening system capable of detecting early signs of Alzheimer’s Disease (AD) using data captured during sessions of standard clinical AD diagnostics. Approximately 50 million people worldwide are diagnosed with dementia. As of 2021, an estimated 6.2 million Americans, one in nine people 65 and older, are living with AD.The majority of affected people do not obtain early screening toward a timely dementia diagnosis. Consequently, there is a large and rapidly growing need for lowcost, non-invasive, and accessible tools for dementia screening toward alerting families and caregivers and encouraging them to pursue medical evaluation. The proposed app is intended for family members and caregivers and will be designed to be easy to use and encourage regular screening. The goal is for the proposed app to enable convenient early flagging of AD for the general public.

View Resource

A mobile app to deliver music-based interventions to combat neuropsychiatric symptoms in people living with AD/ADRD

Awardee Organization(s): AutoTune Me LLC
Principal Investigator(s): Kendra Ray, PhD, MPH, MT-BC
Official Project Title: A Music-Based Mobile App to Combat Neuropsychiatric Symptoms in People Living with ADRD
AITC Partner: PennAITech
Website(s): www.autotuneme.org

The purpose of this pilot project is to develop a mobile application “TuneMind” that detects pulse and sedentary movements of homebound individuals with Alzheimer’s disease and related dementias (ADRD) and triggers auto-play of personalized songs in a wearable device. By collecting quantitative and qualitative data from the app and users, we will test the acceptability and feasibility of the app. This app will be an important tool to include in daily caregiving in a home setting by extending established benefits of music therapy for people with ADRD. The aims are as follows:
Aim 1. Develop TuneMind. TuneMind will be developed to respond to changes in the pattern of heart rate and sedentary behaviors of people with ADRD. An algorithm will be created to (1) find changes of the heart rate to trigger the application to play music; (2) adaptively improve learning when music is needed, e.g., time of day; (3) predict the music dose required to better control heart rate and movement.
Aim 2. Test the usability of the app. A total of 10 stakeholders will be asked to test TuneMind for two weeks. Based on a survey and focus groups, improvements will be made to the app.
Aim 3. Determine the performance and usability of the app for use by people with ADRD and their family caregivers at home. Twenty dyads will be recruited to test TuneMind for two weeks. We will collect physiological measures based on the app’s demonstration to auto-play music according to pulse and/or sedentary states.

View Resource

A2 Awardees

The national a2 Pilot Awards competition is hosted annually by the a2 Collective and funded by the National Institute on Aging (NIA), part of the National Institutes of Health, through the Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program.

NIA has earmarked $40 million to fund demonstration technology projects that utilize artificial intelligence (AI) approaches and technology to improve care and health outcomes for older Americans, including persons with Alzheimer’s disease and related dementias (AD/ADRD) and their caregivers. Selected existing awardees are listed here.

View Resource

A2 Collective Youtube Channel

The AI/Tech + Aging Pilot Awards (a2 Pilot Awards) is a national competition hosted by the a2 Collective and funded by the National Institute on Aging (NIA) through its Artificial Intelligence and Technology Collaboratories for Aging Research (AITC) program.
The NIA has earmarked $40 million over the next 5 years to fund demonstration projects that utilize artificial intelligence approaches and technology to improve care and health outcomes for older Americans, including persons with Alzheimer’s Disease and Related Dementia (AD/ADRD) and their caregivers.

We share a2 Collective videos (e.g., webinars, call for applications) in this youtube channel.

View Resource

A2 National Symposium

The a2 Collective represents the National Institute on Aging (NIA) Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program, which is dedicated to helping Americans live longer, healthier lives through the application of artificial intelligence (AI) and emerging technologies. The a2 Collective comprises three AITCs centered at Johns Hopkins University, the University of Massachusetts Amherst, and the University of Pennsylvania and the a2 Collective Coordinating Center managed by Rose Li & Associates, Inc.

The a2 Collective is organizing a national symposium to be held on March 8, 2023, in Baltimore, MD, on the campus of the Johns Hopkins University School of Medicine. 

View Resource

A2Collective Events

The a2 Collective represents the National Institute on Aging (NIA) Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program, which is dedicated to helping Americans live longer, healthier lives through the application of artificial intelligence (AI) and emerging technologies. The a2 Collective comprises three AITCs centered at Johns Hopkins University, the University of Massachusetts Amherst, and the University of Pennsylvania and the a2 Collective Coordinating Center managed by Rose Li & Associates, Inc.

The a2 Collective is organizing a series of events, including call for proposals, symposia, webinars, etc. 

View Resource

A2Collective Home

The a2 Collective represents the Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program, which is dedicated to helping Americans live longer, healthier lives through the application of artificial intelligence (AI) and emerging technologies.

The AITC program has earmarked $40M to fund promising AI technology pilot projects that seek to improve care and health outcomes for older Americans, including persons with Alzheimer’s disease and related dementias (AD/ADRD). Pilot awardees may receive access to the study sites, datasets, and resources at each AITC as well as mentorship from industry and university experts, major healthcare systems, and venture capitalists.

The AITC program is funded by the National Institute on Aging (NIA), part of the National Institutes of Health.

View Resource

A2Collective Pilot Awards

The national a2 Pilot Awards competition is hosted annually by the a2 Collective and funded by the National Institute on Aging (NIA), part of the National Institutes of Health, through the Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program.

NIA has earmarked $40 million to fund demonstration technology projects that utilize artificial intelligence (AI) approaches and technology to improve care and health outcomes for older Americans, including persons with Alzheimer’s disease and related dementias (AD/ADRD) and their caregivers.

View Resource

AI digital twins using multimodal data to predict AD/ADRD and MCI in older adults

Awardee Organization(s): DreamFace Technologies LLC
Principal Investigator(s): Mohammad H. Mahoor, PhD
Official Project Title: Building Deep Digital Twins for Prediction of AD/ADR/MCI in Older Adults
AITC Partner: PennAITech
Website(s): https://dreamfacetech.com/

The Alzheimer’s Association predicts that the number of Americans aged 65 and older with Alzheimer’s disease-related dementia (ADRD) will reach over 12 million people by 2050. ADRD often stars with mild cognitive impairment (MCI), which is characterized by challenges in memory, language, and thinking skills. Early MCI detection is vital for identifying those at risk of dementia, offering support, advice, and ongoing monitoring. Currently, older adults with MCI are diagnosed clinically; however, their daily challenges are often not noticeable to those whom they encounter irregularly. Artificial Intelligence (AI) holds promise for early cognitive impairment detection, with many AI studies focusing on expensive clinical assessments and medical scans like positron emission tomography (PET) and MRI. There is a pressing need for additional research to advance innovative, cost-effective, and accessible approaches for early detection and prediction of AD and MCI. Human digital twins are at the forefront of aging and longevity research, aiming to create personalized AI models that comprehensively simulate an individual’s behavioral, biological, physical, mental, and socio-emotional attributes using health and medical records. These models hold the potential to revolutionize our understanding, prediction, and management of the aging process, offering personalized healthcare solutions. This pilot project aims to investigate AI techniques that leverage multi-modal audio-visual data, along with other available data modalities, to develop human digital twins for research in aging and, more specifically, for predicting MCI and the early onset of AD/ADRD. We design and implement a Deep Digital Twins (DDT) model using Conditional Variational Autoencoders (CVAEs) suitable for heterogeneous multi-modal data including speech, transcribed speech, and facial videos. We then evaluate the efficacy of the proposed model using publicly available datasets such as the I-CONECT and ADReSS datasets, which contain multi-modal data and other metadata suitable for our project. We hypothesize that DDTs trained using multi-modal comprehensive data can predict MCI/AD with high fidelity and accuracy compared to uni-modal data. We compare our proposed DDT with state-of-the-art models in the literature. We assess the models’ performance, taking into account the impact of diverse data to ensure they remain unbiased. The expected outcome of this research are knowledge and prototyped Deep Digital Twins capable of assessing and predicting MCI/AD conditions in older adults. It is expected that the DDTs generate the longitudinal trajectories sampled from the data as well as predict the subject’s future condition.

View Resource

AI-based advanced care planning platform to align patients and surrogate decision makers to improve end-of-life care

Awardee Organization(s): Koda Health
Principal Investigator(s): Desh Mohan, MD
Official Project Title: Patient-Surrogate Alignment in Digital Advance Care Planning
AITC Partner: PennAITech
Website(s): www.kodahealthcare.com

Advance Care Planning (ACP) encompasses educating patients on potential future healthcare decisions, clarifying patients’ values and healthcare preferences, and sharing decisions with family and care providers. Most individuals lacking decision-making capacity near end-of-life will need a surrogate decision maker (SDM) to make or voice decisions for them. However, less than 25% of SDMs are engaged in the ACP process or aware of patient preferences, and often feel unprepared for decision-making. Koda is a machine learning based ACP platform which offers dynamic educational content, decision guidance, and advanced directive documentation for patients and SDMs. Aims of this study are to: 1) determine motivators of patient-SDM alignment among Koda users and 2) develop a machine learning algorithm to perform SDM persona identification.
Participants will be 50 patient-SDM dyads. Eligible patients will be 50+ years of age, without dementia or blindness. SDMs will be 18+ years old. All participants should have an email address and ability to read and speak English. Following informed consent, patients will complete the Koda ACP platform and a survey about SDMs’ values and experiences. SDMs will complete a self-survey and perceived alignment surveys before and after reviewing the patient’s completed ACP. Survey data will be used to train theSDM persona detection algorithm. Dyads will also be invited to complete qualitative interviews, for further exploration of patient-SDM experiences.This pilot project aims to better understand patientSDM alignments and to develop an algorithm for identification of SDM personas, with the ultimate goal of facilitating increasingly high-quality ACP and goal-concordant care.

View Resource